AGGREGATION BEHAVIOR OF FOSINOPRIL SODIUM - A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR

被引:11
作者
WANG, ZL [1 ]
MORRIS, KR [1 ]
CHU, B [1 ]
机构
[1] SUNY STONY BROOK,DEPT CHEM,STONY BROOK,NY 11794
关键词
D O I
10.1002/jps.2600840516
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Fosinopril sodium is an effective new angiotensin-converting enzyme (ACE) inhibitor that is very useful for the clinical treatment of hypertension. After oral administration, fosinopril sodium is only partially absorbed (about one third of the drug). We studied the solution behavior of fosinopril sodium in aqueous media by a combination of high-resolution nuclear magnetic resonance (NMR) spectroscopy and laser light scattering (LLS). LLS characterizes the self-association properties of fosinopril sodium in solution, and NMR chemical shifts provide information on molecular conformation and interactions. The results revealed that fosinopril sodium has a micelle-like self-association behavior with a critical micelle concentration (cmc) similar to 1.5 mg/mL. Hydrophobic interactions could induce formation of micellar aggregates, which had a narrow hydrodynamic size distribution, with an average diameter of similar to 150 nm at concentrations above the cmc. The surface activity and self-association of fosinopril sodium may be responsible for its early observed concentration-dependent stability in aqueous solution, unexpected decrease in solubility in the presence of metal ions, as well as the limited absorption in clinical studies.
引用
收藏
页码:609 / 613
页数:5
相关论文
共 15 条
[1]   MICELLAR PROPERTIES OF DRUGS - PROPERTIES OF MICELLAR AGGREGATES OF PHENOTHIAZINES AND THEIR AQUEOUS-SOLUTIONS [J].
ATTWOOD, D ;
FLORENCE, AT ;
GILLAN, JMN .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (06) :988-993
[2]  
CHU B, 1985, J POLYM SCI POLYM S, V73, P137
[3]  
DUCHIN KL, 1984, J CLIN PHARMACOL, V24, P422
[4]   PHARMACOKINETICS, SAFETY, AND PHARMACOLOGICAL EFFECTS OF FOSINOPRIL SODIUM, AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR IN HEALTHY-SUBJECTS [J].
DUCHIN, KL ;
WACLAWSKI, AP ;
TU, JI ;
MANNING, J ;
FRANTZ, M ;
WILLARD, DA .
JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (01) :58-64
[5]  
GRSHOWSKI ZF, 1983, MEASUREMENTS SUSPEND
[6]   MICELLE SIZE AND SHAPE OF SODIUM DODECYL-SULFATE IN CONCENTRATED NACL SOLUTIONS [J].
HAYASHI, S ;
IKEDA, S .
JOURNAL OF PHYSICAL CHEMISTRY, 1980, 84 (07) :744-751
[7]   PHARMACOKINETICS OF FOSINOPRIL IN PATIENTS WITH VARIOUS DEGREES OF RENAL-FUNCTION [J].
HUI, KK ;
DUCHIN, KL ;
KRIPALANI, KJ ;
CHAN, D ;
KRAMER, PK ;
YANAGAWA, N .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (04) :457-467
[8]   MICELLAR PROPERTIES OF DRUGS - MICELLAR AND NONMICELLAR PATTERNS OF SELF-ASSOCIATION OF HYDROPHOBIC SOLUTES OF DIFFERENT MOLECULAR-STRUCTURES - MONOMER FRACTION, AVAILABILITY, AND MISUSES OF MICELLAR HYPOTHESIS [J].
MUKERJEE, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (06) :972-981
[9]   FOSINOPRIL - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN ESSENTIAL-HYPERTENSION [J].
MURDOCH, D ;
MCTAVISH, D .
DRUGS, 1992, 43 (01) :123-140
[10]   RELATIVE LIPOPHILICITIES AND STRUCTURAL PHARMACOLOGICAL CONSIDERATIONS OF VARIOUS ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS [J].
RANADIVE, SA ;
CHEN, AX ;
SERAJUDDIN, ATM .
PHARMACEUTICAL RESEARCH, 1992, 9 (11) :1480-1486